OCGN Q4 2024 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$764,000-87.3% YoY

Gross Profit

$764,000100.0% margin

Operating Income

-$14M-1811.5% margin

Net Income

-$14M-1816.8% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-32.7%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$82M

Total Liabilities

$53M

Stockholders' Equity

$30M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$764,000	$6M	-87.3%
Gross Profit	$764,000	$6M	-87.3%
Operating Income	-$14M	-$9M	-60.5%
Net Income	-$14M	-$9M	-46.2%